Clinical Trial Update: Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors

View source ↗

Summary

The update discusses circulating melanoma cells in metastatic melanoma patients treated with selective BRAF inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Selective BRAF inhibitors (BRAF inhibitor)

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Metastatic Melanoma | Status: UNKNOWN